Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Effect of LiFE-SePBT on Postural Stability in Community-dwelling Older Adults: an Assessor-blinded Randomised Controlled Trial (LiFE-SePBT)

maanantai 28. syyskuuta 2026 päivittänyt: TSANG Sau Lan Charlotte, The Hong Kong Polytechnic University

Combined Effects of Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Training on Postural Stability in Community-dwelling Older Adults: an Assessor-blinded Randomised Controlled Trial

This study is an assessor-blinded randomised controlled trial investigating the effects of combined Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Training (LiFE-SePBT) on postural stability in community-dwelling older adults with an elevated risk of falling.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

Participants will be randomly assigned to two groups: LiFE-SePBT or an attention control group. All participants will provide their written informed consent before baseline assessment. The study will be reported and conducted in line with the CONSORT statement. Participants will be recruited via convenience sampling in the local community. After baseline assessment, both groups will receive five 90-minute intervention sessions over 10 weeks. Between-group differences in behaviour will be examined before and after training to identify immediate training-induced changes in postural stability. Retention of the changes in postural stability will be assessed four months after the training period. Fall incidents will be followed up for 12 months after training.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

44

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

    • Kowloon
      • Hung Hom, Kowloon, Hong Kong, 000
        • Rekrytointi
        • The Hong Kong Polytechnic University
        • Ottaa yhteyttä:

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

60 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Community-dwelling older adults aged 60 or older
  • Able to communicate effectively in Cantonese or Mandarin
  • Able to walk independently on level ground for at least 30 minutes
  • A score of ≥ 6 in the Abbreviated Mental Test (Hong Kong)
  • Have fallen in the preceding year, have concerns about falling, or feel unsteady while walking or standing

Exclusion Criteria:

  • Uncorrected vision or hearing impairment
  • Osteoporosis
  • Hip or knee replacement within the last year
  • Resting blood pressure ≥ 160/100 mmHg even with medication taken
  • A score of ≤ 6 in 5-items Geriatric Depression Scale (GDS-5)
  • Have musculoskeletal, cardiovascular, mental, or neurological disorders that preclude their participation in the assessment or intervention safety

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Kaksinkertainen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: LiFE-SePBT

5 sessions of combined Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Training (LiFE-SePBT) will be delivered. The LiFE component involves having participants embed functional exercises into their lifestyle, as well as practising recovering their balance upon self-initiated perturbation. Each session is 90 minutes long and will be hosted once every 2 weeks.

Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Exercise (LiFE-SePBT) is a synergistic fall prevention programme. LiFE programme targets generic balance and muscle strength whereas SePBT mainly influences through reactive balance.

Placebo Comparator: Attention control group

Participants in the attention control group will receive 5 sessions of upper limb mobilisation and flexibility exercises. Each session is 90 minutes long and will be held once every 2 weeks.

Upper limb mobilisation and flexibility training, including arm circles, deltoid stretches, shoulder internal rotations, etc.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Generic Balance ability
Aikaikkuna: Week 0 (baseline assessment), week 10 (post-assessment), week 22 (i.e., 3-month follow-up assessment)

Generic balance ability will be assessed by the Mini-BESTest. Mini-BESTest can challenge balance across anticipatory postural adjustments, postural responses, sensory orientation and stability in gait, allowing for a comprehensive examination of improvements that occur in reactive control.

Week 0 (baseline assessment), week 10 (post-assessment), week 22 (i.e., 3-month follow-up assessment)

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Number of real-life falls
Aikaikkuna: 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months after the intervention.

The number of real-life falls in months after randomization will be recorded. Fall circumstances and related injuries will be required via phone contact. A fall is defined as an event resulting in a person unintentionally coming to rest on the ground or other lower level, not as the result of a major intrinsic event (e.g., syncope, stroke, or overwhelming hazard such as an earthquake).

1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months after the intervention.
Dynamic balance
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Dynamic balance will be assessed by Alternative Step Test (in the unit of seconds).

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Balance confidence
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Balance confidence will be measured with the Chinese version of the shortened version of Activities-specific Balance Confidence Scale (ABC-6). The scale value is from 0 to 100, with higher values representing higher balance confidence.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Functional lower body strength
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Functional lower body strength will be assessed by Five-time Sit to Stand Test (in the unit of seconds).

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Number of laboratory falls
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Participants will be exposed to one trip-like perturbation and slip-like perturbation on each foot at an unexpected time. The number of falls upon perturbations will be recorded.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Depressive symptoms
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Depressive symptoms will be assessed by Five-Item Geriatric Depression Scale. Participants will be asked to answer 5 questions as yes or no. The answer "no" for the first question and "yes" for the other four questions will be evaluated for depression.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Health-related quality of life
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Health-related quality of life will be assessed by the EQ-5D-5L. In the EQ-5D-5L descriptive system, each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. Each health state is identified by a five-digit code, with 11111 representing the best and 55555 the worst possible health state.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Muscle activations
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Muscle activations will be assessed by surface electromyography using an electromyography system (Trigno IM, Delsys Inc., Natick, MA, USA). Fourteen electrodes are placed bilaterally over erector spinae, rectus abdominis, gastrocnemius medialis, biceps femoris, rectus femoris, tibialis anterior, and gluteus medius according to the SENIAM guidelines (www.seniam.org) by the physical therapist.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Physical activity
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Physical activity will be assessed by the Physical Activity Scale for the Elderly. This questionnaire will ask participants to recall their activity over the last 7-days. Activity types include sitting, walking, sport/recreation, exercise, occupational and household. A total score for physical activity can be calculated using these answers and the predetermined weights associated with each activity.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Cognitive flexibility and executive function
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Cognitive flexibility and executive function will be assessed by Trial Making Tests A and B (in the unit of seconds).

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Perceived ability to execute reactive stepping
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

The perceived ability to execute reactive stepping in different scenarios in real life situations via Short-Form Balance Recovery Confidence (SF-BRC) Scale. Each item is ranked from 0-10.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
Exercise adherence
Aikaikkuna: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Exercise adherence will be measured via the Chinese version of Exercise Adherence Rating Scale (EARS-C). The total score of this scale is ranked between 0 to 24; each item is graded from 0 to 4 while item 1, 4 and 6 are reverse-scored.

Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Charlotte Sau Lan Tsang, PhD, The Hong Kong Polytechnic University

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Perjantai 12. kesäkuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Sunnuntai 17. joulukuuta 2028

Opintojen valmistuminen (Arvioitu)

Maanantai 17. joulukuuta 2029

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Maanantai 21. syyskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Maanantai 21. syyskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Perjantai 25. syyskuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Torstai 1. lokakuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Maanantai 28. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

Due to participant privacy concerns.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa